Global Next-generation Sequencing Market Analysis with Forecasts to 2022 | Growth Opportunities
The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion by 2022.
The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2015, 2016, 2017 and 2022.
The main market driving forces are also discussed.
The report examines the markets by test complexity, clinical indication and test purpose. Test complexity refers to the plex level (i.e., the number of genetic markers that can be analyzed within a sample) and coverage (e.g., the extent to which the genome is covered) of the test.
Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics,.) will be in demand in the future.
The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, cardiovascular diseases, clinical microbiology and infectious diseases, Mendelian disorders, metabolic and immune disorders, neurological disorders, reproductive health, and transplant medicine.
Specific geographic markets are discussed, including North America, Europe, Asia-Pacific, and the rest of the world.
Industry sectors analyzed include sequencing instruments, target enrichment, informatics, clinical laboratory testing services, reproductive health diagnostics, liquid biopsy, immune sequencing, HLA typing, third generation sequencing, and direct to consumer.
More than 200 companies in the clinical NGS industry are profiled in this report.
Research Cosmos provides a summary of the main industry acquisitions and strategic alliances from 2015 through April 2017, including key alliance trends.
- An overview of the global market for next-generation sequencing and its emerging clinical applications.
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Examination of the sequencing industry structure for key market segments.
- Discussion covering the strategies employed by the main companies in the market.
- Comprehensive company profiles of major players in the field.
For more information:Make an Inquiry about this report HERE!